Dancing with DPP-1: The Inflammatory Tango of Bronchiectasis

Grant W Waterer^{1

2}, Sanjay H Chotirmall^{3

4}

Affiliations

¹ School of Medicine University of Western Australia Perth, Western Australia, Australia.
² Feinberg School of Medicine Northwestern University Chicago, Illinois.
³ Lee Kong Chian School of Medicine Nanyang Technological University Singapore.
⁴ Department of Respiratory and Critical Care Medicine Tan Tock Seng Hospital Singapore.

Editorial

Grant W Waterer et al. Am J Respir Crit Care Med. 2025 May.

. 2025 May;211(5):678-679.

doi: 10.1164/rccm.202501-0032ED.

Grant W Waterer^{1

2}, Sanjay H Chotirmall^{3

4}

¹ School of Medicine University of Western Australia Perth, Western Australia, Australia.
² Feinberg School of Medicine Northwestern University Chicago, Illinois.
³ Lee Kong Chian School of Medicine Nanyang Technological University Singapore.
⁴ Department of Respiratory and Critical Care Medicine Tan Tock Seng Hospital Singapore.

No abstract available

Comment on

Broad Immunomodulatory Effects of the Dipeptidyl Peptidase-1 Inhibitor Brensocatib in Bronchiectasis: Data from the Phase 2, Double-Blind, Placebo-controlled WILLOW Trial.
Johnson ED, Long MB, Perea L, Shih VH, Fernandez C, Teper A, Cipolla D, McIntosh E, Galloway R, Eke Z, Shuttleworth M, Hull R, Spinou A, De Soyza A, Ringshausen FC, Goeminne P, Lorent N, Haworth C, Loebinger MR, Blasi F, Shteinberg M, Aliberti S, Polverino E, Sibila O, Shoemark A, Mange K, Huang JTJ, Stobo J, Chalmers JD. Johnson ED, et al. Am J Respir Crit Care Med. 2025 May;211(5):770-778. doi: 10.1164/rccm.202408-1545OC. Am J Respir Crit Care Med. 2025. PMID: 39938076 Clinical Trial.

1. Chotirmall SH, Chalmers JD. The precision medicine era of bronchiectasis. Am J Respir Crit Care Med . 2024;210:24–34. - PMC - PubMed
1. Waterer GW. What changes in research focus do we need to advance care for patients with bronchiectasis? Am J Respir Crit Care Med . 2024;210:22–23. - PMC - PubMed
1. Shteinberg M, Waterer G, Chotirmall SH. A global effort to stop the vicious vortex: a special American Journal of Respiratory and Critical Care Medicine issue for World Bronchiectasis Day 2024. Am J Respir Crit Care Med . 2024;210:1–3. - PMC - PubMed
1. Chalmers JD, Haworth CS, Metersky ML, Loebinger MR, Blasi F, Sibila O, et al. WILLOW Investigators Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. N Engl J Med . 2020;383:2127–2137. - PubMed
1. Metersky M, Burgel PR, Daley CL, Soyza A, Haworth CS, Mauger D, et al. Annualized exacerbation rate in patients with non-cystic fibrosis bronchiectasis by prespecified subgroups in the PH3, randomized, double-blind, placebo-controlled ASPEN trial [abstract] Chest . 2024;166:A6554–A6556.